Cargando…
Complete Remission of Mouse Melanoma after Temporally Fractionated Microbeam Radiotherapy
SIMPLE SUMMARY: Synchrotron Microbeam Radiation Therapy (MRT) provides excellent tumour control in preclinical cancer models. Most of the results obtained in the field employ average peak doses between 300 and 600 Gy. However, despite its proven efficacy, one of the biggest challenges in translating...
Autores principales: | Fernandez-Palomo, Cristian, Trappetti, Verdiana, Potez, Marine, Pellicioli, Paolo, Krisch, Michael, Laissue, Jean, Djonov, Valentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563854/ https://www.ncbi.nlm.nih.gov/pubmed/32957691 http://dx.doi.org/10.3390/cancers12092656 |
Ejemplares similares
-
Animal Models in Microbeam Radiation Therapy: A Scoping Review
por: Fernandez-Palomo, Cristian, et al.
Publicado: (2020) -
Targeted Accumulation of Macrophages Induced by Microbeam Irradiation in a Tissue-Dependent Manner
por: Trappetti, Verdiana, et al.
Publicado: (2022) -
Microbeam Radiotherapy—A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma
por: Trappetti, Verdiana, et al.
Publicado: (2021) -
Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice
por: Potez, Marine, et al.
Publicado: (2018) -
Erratum: Fernandez-Palomo, C., et al. Animal Models in Microbeam Radiation Therapy: A Scoping Review. Cancers 2020, 12, 527
por: Fernandez-Palomo, Cristian, et al.
Publicado: (2020)